Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Weigang

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Chemmedchem|February 3, 2018
CHIPMUNK: A Virtual Synthesizable Small-Molecule Library for Medicinal Chemistry, Exploitable for Protein-Protein Interaction ModulatorsLina Humbeck, Sebastian Weigang, Till Schäfer, et al.
Viruses|August 28, 2025
SARS-CoV-2 Nsp1 Is a Major Suppressor of HLA Class I and Class II ExpressionIvo Schirmeister, Nicolas Eckert, Sebastian Weigang, et al.
NPJ Vaccines|July 25, 2022
Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2Adriano Taddeo, Inês Berenguer Veiga, Christelle Devisme, et al.
Journal of Virology|June 29, 2018
Human MxB Protein Is a Pan-herpesvirus Restriction FactorMirjam Schilling, Lorenzo Bulli, Sebastian Weigang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 2, 2022
Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiencyJulia R Hirsiger, Sebastian Weigang, Antje-Christine Walz, et al.
Elife|April 27, 2022
The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesvirusesManutea C Serrero, Virginie Girault, Sebastian Weigang, et al.
Nature Communications|November 5, 2021
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variantsSebastian Weigang, Jonas Fuchs, Gert Zimmer, et al.
Nature Communications|April 10, 2023
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patientLena Jaki, Sebastian Weigang, Lisa Kern, et al.
The Journal of Allergy and Clinical Immunology|November 22, 2020
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19Carlo Cervia, Jakob Nilsson, Yves Zurbuchen, et al.
Cell Reports. Medicine|November 9, 2020
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial CellsAlexander Carpinteiro, Michael J Edwards, Markus Hoffmann, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Chemmedchem|February 3, 2018
CHIPMUNK: A Virtual Synthesizable Small-Molecule Library for Medicinal Chemistry, Exploitable for Protein-Protein Interaction ModulatorsLina Humbeck, Sebastian Weigang, Till Schäfer, et al.
Viruses|August 28, 2025
SARS-CoV-2 Nsp1 Is a Major Suppressor of HLA Class I and Class II ExpressionIvo Schirmeister, Nicolas Eckert, Sebastian Weigang, et al.
NPJ Vaccines|July 25, 2022
Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2Adriano Taddeo, Inês Berenguer Veiga, Christelle Devisme, et al.
Journal of Virology|June 29, 2018
Human MxB Protein Is a Pan-herpesvirus Restriction FactorMirjam Schilling, Lorenzo Bulli, Sebastian Weigang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 2, 2022
Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiencyJulia R Hirsiger, Sebastian Weigang, Antje-Christine Walz, et al.
Elife|April 27, 2022
The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesvirusesManutea C Serrero, Virginie Girault, Sebastian Weigang, et al.
Nature Communications|November 5, 2021
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variantsSebastian Weigang, Jonas Fuchs, Gert Zimmer, et al.
Nature Communications|April 10, 2023
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patientLena Jaki, Sebastian Weigang, Lisa Kern, et al.
The Journal of Allergy and Clinical Immunology|November 22, 2020
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19Carlo Cervia, Jakob Nilsson, Yves Zurbuchen, et al.
Cell Reports. Medicine|November 9, 2020
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial CellsAlexander Carpinteiro, Michael J Edwards, Markus Hoffmann, et al.
Pageof 2